| Sean E Rubendall, CRNA | |
|
809 82nd Pkwy, Myrtle Beach, SC 29572-4607 | |
| (843) 692-4062 | |
| Not Available |
| Full Name | Sean E Rubendall |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 809 82nd Pkwy, Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184920993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 4428 (South Carolina) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | AP128150 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ennis Regional Medical Center | Ennis, TX | Hospital |
| Parkview Regional Hospital | Mexia, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergenchealth Pllc | 1355606641 | 585 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | U S Anesthesia Partners Of Texas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Waxahachie Anesthesia Consultant Services Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104803089 PECOS PAC ID: 7810950888 Enrollment ID: O20041110000655 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Metroplex Anesthesia Consultants, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427209790 PECOS PAC ID: 2062576119 Enrollment ID: O20090204000312 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Clinical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518265966 PECOS PAC ID: 8325217904 Enrollment ID: O20110816000816 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Youngs Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20120104000614 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Endo Sedation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588931174 PECOS PAC ID: 4789845363 Enrollment ID: O20120406000221 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Champion Anesthesia Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649676024 PECOS PAC ID: 7113231358 Enrollment ID: O20150803000277 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Anesthesia Partners Of Dallas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760841969 PECOS PAC ID: 7810293438 Enrollment ID: O20160308002281 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Panhandle Anesthesia Services, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477908408 PECOS PAC ID: 7911299342 Enrollment ID: O20160706000389 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Emergenchealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467970897 PECOS PAC ID: 1355606641 Enrollment ID: O20180608000439 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Entity Name | Ntx Anesthesiology Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912410739 PECOS PAC ID: 7416203773 Enrollment ID: O20180629000441 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean E Rubendall, CRNA Po Box 1792, Columbia, SC 29202-1792 Ph: () - | Sean E Rubendall, CRNA 809 82nd Pkwy, Myrtle Beach, SC 29572-4607 Ph: (843) 692-4062 |
News Archive
Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Targeted and individually adapted information to the parents of small children would reduce the risk of accidents involving children in the home. This is shown by new research from the Faculty of Health and Society at Malmö University in Sweden.
Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.
› Verified 7 days ago
Travis Mills, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2432 Hunters Trl, Myrtle Beach, SC 29588 Phone: 423-736-0357 | |
Patrick E Quinn, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-692-1062 | |
Jane I Dickman, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-692-1062 | |
Jean M. Vinski, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-692-1062 | |
Deborah Marie Rambo, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 809 82nd Pkwy, Anesth Dept, Myrtle Beach, SC 29572 Phone: 843-692-1000 | |
Debra K Hamerski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7900 N Kings Hwy, Myrtle Beach, SC 29572 Phone: 843-449-3381 | |
Irina Walker, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-602-2408 |